Makers Laboratories MD, chairman, board of directors and AGM
NSE: MAKERSLBSE: 506919Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 23 Oct 2026. Previous close ₹198.66.
- Next results date: the board meets on 4 Nov 2026 to consider: quarterly results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹110 Cr3,027th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 7 Aug 2026
- 32.3
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 26 May 2026
- 1.5
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 7 Aug 2026
- 4.8%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 7 Aug 2026
- 11.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 26 May 2026
- 0.04
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 4,74377.2% delivered
Makers Laboratories board of directors
At the end of the quarter to Sep 2026, as the company filed it; changes since are in its announcements.Their trades in its shares
- ChairpersonRaj Kamal Prasad Verma
- Company Secretary and Compliance OfficerPIYUSH AJMERA
6 directors3 independent1 executive2 non-executive
- Saahil ParikhNon-executive · joined Aug 2011 · reappointed Aug 2023 · 1 listed board · 1 committee seat
- Nilesh JainExecutive · joined Feb 2019 · reappointed Feb 2025 · 2 listed boards · 1 committee seat
- Dipti ShahIndependent · joined Jan 2018 · reappointed Jan 2023 · 104 months as independent · 2 listed boards · 2 as independent · 3 committee seats
- Raj Kamal Prasad Verma · ChairpersonIndependent · joined Feb 2019 · reappointed Feb 2024 · 92 months as independent · 2 listed boards · 2 as independent · 2 committee seats, 2 as chair
- Vishal JainIndependent · joined Nov 2020 · reappointed Nov 2025 · 71 months as independent · 1 listed board · 1 as independent · 1 committee seat, 1 as chair
- Prashant GodhaNon-executive · joined Nov 2020 · 4 listed boards · 1 committee seat
An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.
Committees and meetings
Who sits on each, and how often they met.Board meeting notices and outcomes
Board
- 7 Aug 20266 of 6 present3 independent · 72 days in between
- 26 May 20266 of 6 present3 independent
Audit Committee
Chair Vishal Jain
Raj Kamal Prasad Verma, Dipti Shah, Nilesh Jain
- 7 Aug 20264 of 4 present3 independent · 72 days in between
- 26 May 20264 of 4 present3 independent
Nomination and remuneration committee
Chair Vishal Jain
Raj Kamal Prasad Verma, Dipti Shah
- 7 Aug 20263 of 3 present3 independent · 72 days in between
- 26 May 20263 of 3 present3 independent
Stakeholders Relationship Committee
Chair Raj Kamal Prasad Verma
Vishal Jain, Saahil Parikh
- 26 May 20263 of 3 present2 independent
Risk Management Committee
Saahil Parikh, Nilesh Jain, Sandeep Kadam
- 26 May 20263 of 3 present1 independent
Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.
Statutory auditor
Named in the results for the quarter to Mar 2026.
- NVC & Associates LLPPeer-review certificate valid to Jul 2027
1 earlier auditor
- Natvarlal Vepari & Co. LLPNamed in the filing for the quarter to Mar 2025
A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.
Makers Laboratories AGM and shareholder votes
Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Makers Laboratories dividend history
Postal ballot, 16 Oct 2026
3,972 shareholders on the register on 11 Sep 2026; votes counted by Ms. Jigyasa N. Ved / Parikh & Associates.The company's voting result (opens in a new tab)
- Appointment of Mr. Saahil Parikh (DIN 00400079) as a Non-Executive, Non-Independent Director of the Company liable to retire by rotation.Ordinary99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 0.16%
Turnout: all 64.25% · promoters 100.00% · institutions 0.00% · other public 7.76%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Annual general meeting, 7 Aug 2026, 4 resolutions
3,821 shareholders on the register on 31 Jul 2026; present: 6 promoters and 35 others; votes counted by Ms. Jigyasa N. Ved / Parikh & Associates.The company's voting result (opens in a new tab)
1 - a) Adoption of Audited Financial Statements for the financial year ended 31st March 2026, Reports of the Board of Directors and Auditors thereon b) Adoption of Audited Consolidated Financial Statements for the financial year ended on 31st March 2026 and Report of the Auditors thereonMoreLess
Ordinary99.99% for0.01% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.35%
Turnout: all 62.55% · promoters 100.00% · institutions 0.00% · other public 3.32%
- 2 - To appoint a Director in place of Mr. Saahil Parikh (DIN 00400079), who retires by rotation, and being eligible offers himself for re-appointment.Ordinary99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 0.37%
Turnout: all 62.55% · promoters 100.00% · institutions 0.00% · other public 3.32%
- 3 - Approval for related party transactions with Ipca Laboratories Ltd. (Ordinary Resolution).OrdinaryPromoters have an interest in it99.63% for0.37% against
Against: promoters 0.00% · institutions 0.00% · other public 0.37%
Turnout: all 1.27% · promoters 0.00% · institutions 0.00% · other public 3.30%
- 4 - Ratification of remuneration payable to Cost Auditors for financial year 2026-27 (Ordinary Resolution).Ordinary99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 0.35%
Turnout: all 62.55% · promoters 100.00% · institutions 0.00% · other public 3.32%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Investor complaints and compliance
Quarter by quarter.
Investor complaints received and resolved, the company's own count
- Received
- Resolved
Open at the quarter's end
- The board is made up as the listing rules require
- Yes
- The board has a regular chairperson
- Yes
- The company has a risk management committee
- No
- The chair is related to the managing director
- No
- The filing has a part on fines and penalties
- No
- The filing has a part on tax disputes
- No
- There was a cyber security incident in the quarter
- No
The company's own answers in its filing.